Let’s elect candidates who will make the wealthy pay taxes
We can use some of those revenues to make Social Security contributions more equitable.
We can use some of those revenues to make Social Security contributions more equitable.
Munis were slightly weaker on Friday, as U.S. Treasuries cheapened and equities ended higher. Processing Content Muni yields cheapened by up to two basis points. USTs cheapened by three to five basis points outside of the one-year mark. Monday will bring the second-highest semi-monthly reinvestment of the year, but the week could still be a…
PBOC sets USD/ CNY mid-point today at 6.7910 (vs. estimate at 6.7965) !“#$%&‘()*+,–./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|} !“#$%&‘()*+,–./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}
“These mountains to the right are the northern tip of the Alps, and they are actually in Germany. And over there is the Eagle’s Nest, a chalet perched on a mountaintop, which was Hitler’s 50th birthday present.” We are getting a history and geography lesson from our taxi driver as we set off from Salzburg…
United Kingdom equities offer investors developed market exposure to resilient, globally diversified sector leaders in energy, healthcare, and finance through ETFs. However, exposure requires an understanding of how regional and country-specific funds handle allocations to the UK. Prospective investors seeking exposure must decide between direct single-country funds or broader European strategies where UK inclusion can…
The clouds of debt maturities and nonperforming loans haven’t entirely cleared from the country’s largest banks, but the shine of artificial intelligence and data center development is erasing the shadows cast by Wall Street’s anxieties over pandemic-era loans. AI dominated the conversation across earnings calls for five of the country’s largest banks Tuesday as concerns…
Companies must evolve to stay relevant in the pharmaceutical industry. Teva Pharmaceutical Industries (TEVA -1.19%) is in the midst of its own transformation, from making generic drugs and biosimilars to novel drugs that are beginning to deliver growth and profits that are catching Wall Street’s eye. Every single Wall Street analyst polled by CNN Business…